×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 7 – Benefit-Risk and Risk Management
Session Chair(s)
Michael Richardson, MD, FFPM, FRCP
Senior Vice President, WorldWide Patient Safety
Bristol-Myers Squibb, United Kingdom
William Gregory, PhD
Senior Director, Safety and Risk Management
Pfizer Inc, United States
Session 7 – Benefit-Risk and Risk Management
Speaker(s)
Benefit-Risk: Interface with Risk Management
Susan Welsh
Bristol Myers Squibb, Co., United States
Vice President, Medical Safety
Benefit-Risk Work Streams: Quantitative vs. Qualitative
Rebecca Noel, DrPH, MPH
Eli Lilly, United States
Executive Director, Benefit-Risk Assessment
Benefit-Risk from a Regulator's Perspective
Sara L. Eggers, PhD
FDA, United States
Director, Decision Support and Analysis Team, OSP, CDER
Have an account?